Campbell, CA, United States of America

Claire Marjoribanks

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Claire Marjoribanks: Innovator in Nucleic Acid Detection

Introduction

Claire Marjoribanks is a prominent inventor based in Campbell, CA (US). She has made significant contributions to the field of molecular biology, particularly in the synthesis and detection of nucleic acids. With a total of 2 patents, her work has advanced the methodologies used in genetic research and diagnostics.

Latest Patents

Claire's latest patents focus on compositions, kits, and methods for the synthesis and detection of nucleic acids. One of her notable inventions includes a composition comprising a thermostable DNA polymerase and a PCR inhibitor blocking agent. This innovative blocking agent is present in an amount effective to enhance the tolerance of an assembled PCR to a PCR inhibitor. This advancement is crucial for improving the reliability of PCR techniques in various applications.

Career Highlights

Claire Marjoribanks is currently associated with Life Technologies Corporation, where she continues to push the boundaries of genetic research. Her expertise in molecular biology has positioned her as a key player in the development of new technologies that facilitate the detection and analysis of nucleic acids.

Collaborations

Some of her notable coworkers include Christopher Trinh and Tom Cheng Xu. Their collaborative efforts contribute to the innovative environment at Life Technologies Corporation, fostering advancements in the field.

Conclusion

Claire Marjoribanks exemplifies the spirit of innovation in the realm of molecular biology. Her contributions through her patents and work at Life Technologies Corporation have significantly impacted the field of nucleic acid detection.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…